Powered By
Overview
Erlotinib is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic non-small cell lung cancer (NSCLC). It is specifically used in those whose tumors have EGFR exon 19 deletions…
The Tarceva brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
Join
Your Privacy Choices
